2 directors just resigned from the drug company formerly run by Martin Shkreli
Tom Fernandez and Marek Biestek resigned from KaloBios' board of directors, according to an 8-K filed Monday December 27 with the Securities and Exchange Commission.
It's the latest in a wave of departures of top execs from the company, which is set to de-list from the Nasdaq.
It has been a turbulent December for the San Francisco-based biopharmaceutical company, which saw its stock soar in November after Shkreli bought a majority stake in the company, only to see stock plummet after his arrest.
After falling by more than 50% in the wake of Shkreli's arrest, KaloBios shares were down another 5% at the open Monday December 27.